Back
Alnylam Pharmaceuticals Stock Price Chart
Sponsored
ALNY
Sponsored
BREAKING: Elon Musk's Secret A.I. Project Set to Plunge Millions of Americans Into Poverty
Click here now to prepare yourself for what's around the corner
Sell
28
ALNY
Alnylam Pharmaceuticals
Last Price:
150.14
Seasonality Move:
18.94%
7 Day Trial
ALL ACCESS PASS
$
7
This DeFi Coin Could 10x Soon... I Advise You Get In Now!
Discover this DeFi diamond before the next surge- The current trend is relatively stagnant and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
Alnylam Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 145.48 | Buy |
20-day SMA: | 148.17 | Buy |
50-day SMA: | 150.12 | Sell |
200-day SMA: | 171.94 | Sell |
8-day EMA: | 146.25 | Buy |
20-day EMA: | 147.41 | Buy |
50-day EMA: | 152.23 | Sell |
200-day EMA: | 169.4 | Sell |
Alnylam Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.71 | Sell |
Relative Strength Index (14 RSI): | 53.03 | Buy |
Chaikin Money Flow: | 367415 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (144.91 - 152.87) | Buy |
Bollinger Bands (100): | (147.47 - 183.29) | Sell |
Alnylam Pharmaceuticals Technical Analysis
Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Alnylam Pharmaceuticals Stock
Is Alnylam Pharmaceuticals Stock a Buy?
- Alnylam Pharmaceuticals share price is 149.96 while ALNY 8-day simple moving average is 145.48, which is a Buy signal.
- The stock price of ALNY is 149.96 while Alnylam Pharmaceuticals 20-day SMA is 148.17, which makes it a Buy.
- Alnylam Pharmaceuticals 50-day simple moving average is 150.12 while ALNY share price is 149.96, making it a Sell technically.
- ALNY stock price is 149.96 and Alnylam Pharmaceuticals 200-day simple moving average is 171.94, creating a Sell signal.
ALNY Technical Analysis vs Fundamental Analysis
Sell
28
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy or a Sell?
-
Alnylam Pharmaceuticals stock is rated a Sell
The current Alnylam Pharmaceuticals [ALNY] share price is $149.96. The Score for ALNY is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
Alnylam Pharmaceuticals Stock Info
Market Cap:
18.89B
Price in USD:
149.96
Share Volume:
732.08K
Alnylam Pharmaceuticals 52-Week Range
52-Week High:
218.88
52-Week Low:
141.98
Sell
28
Alnylam Pharmaceuticals (ALNY)
is a Sell
Alnylam Pharmaceuticals Share Price Forecast
-
What is the Alnylam Pharmaceuticals stock price today?
The Alnylam Pharmaceuticals stock price is 149.96 USD today. -
Will ALNY stock go up or go down?
Alnylam Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Alnylam Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Alnylam Pharmaceuticals is overvalued.
Is Alnylam Pharmaceuticals Stock a Buy?
- Alnylam Pharmaceuticals share price is 149.96 while ALNY 8-day exponential moving average is 146.25, which is a Buy signal.
- The stock price of ALNY is 149.96 while Alnylam Pharmaceuticals 20-day EMA is 147.41, which makes it a Buy.
- Alnylam Pharmaceuticals 50-day exponential moving average is 152.23 while ALNY share price is 149.96, making it a Sell technically.
- ALNY stock price is 149.96 and Alnylam Pharmaceuticals 200-day simple moving average is 169.40, creating a Sell signal.
Fundamental Analysis of Alnylam Pharmaceuticals
Is Alnylam Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.39 per share, an increase next quarter of $0.04 per share, a decrease this year of $0.49 per share, and an increase next year of $1.85 per share.
Technical Analysis of Alnylam Pharmaceuticals
Should I short Alnylam Pharmaceuticals stock?
- ALNY Moving Average Covergence Divergence (MACD) indicator is -1.71, suggesting Alnylam Pharmaceuticals is a Sell
- Alnylam Pharmaceuticals Relative Strength Index (RSI) is 53.03, which suggest Alnylam Pharmaceuticals is overbought
- The Bollinger Bands (25) for Alnylam Pharmaceuticals is (144.91 - 152.87), which suggest Alnylam Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Alnylam Pharmaceuticals is (147.47 - 183.29), which suggest Alnylam Pharmaceuticals is a Sell
* Alnylam Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.